Trial Site Detail


QINLOCK Ripretinib DCC-2618
A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Active, not recruiting


Stanford Cancer Center

875 Blake Wilbur Drive     
Palo Alto , CA 94304


Principal Investigator:
General Questions: (650) 498-7425 Cancer Clinical Trials: (650) 498-7061 Institutional Review Board: (866) 680-2906
Activation Status of this Site:
Notes about this Site:
Stanford Cancer Center Website:



Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.